β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53–MDM2 Interaction in Colorectal Cancer-Reference-Cited by-同舟云学术

β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53–MDM2 Interaction in Colorectal Cancer

Published:2020-03-13 Issue:12 Volume:68 Page:3850-3858
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Wang Ziyuan¹²,Zhan Yueping³,Xu Jian³,Wang Yang¹,Sun Mingyu⁴²,Chen Jia¹,Liang Tingyu¹,Wu Lili¹,Xu Ke³^ORCID

Affiliation:

1. Department of Pathology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai 201203, China

2. Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China

3. Interventional Cancer Institute of Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, 164 Lanxi Road, Shanghai 200062, China

4. Key Laboratory of Liver and Kidney Diseases, Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai 201203, China

Funder

National Natural Science Foundation of China

Shanghai Rising-Star Program

Publisher

American Chemical Society (ACS)

Subject

General Agricultural and Biological Sciences,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jafc.0c00107

Reference42 articles.

1. Targeting multidrug resistance in cancer

2. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance